CVRX · CVRx, Inc. · Investor Relations
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-09-29 |
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
MINNEAPOLIS, Sept. 29, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today the schedule of scientific presentations |
| 2026-09-21 |
CVRx Appoints John Landry as Chief Financial Officer
Landry Brings Two Decades of Medtech and Public Company Finance Experience MINNEAPOLIS, Sept. 21, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for |
| 2026-08-25 |
CVRx Responds to Letter from Pointillist Family Office
MINNEAPOLIS, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today issued the following statement |
| 2026-08-24 |
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
MINNEAPOLIS, Aug. 24, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Devoted Health |
| 2026-08-11 |
CVRx Announces Sales Leadership Transition
Robert John to Depart as Chief Revenue Officer; Paul Verrastro Named Interim Head of Sales MINNEAPOLIS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation |
| 2026-08-06 |
CVRx Reports Second Quarter 2026 Financial and Operating Results
MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and |
| 2026-07-28 |
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference
MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management |
| 2026-07-23 |
CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026
MINNEAPOLIS, July 23, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to |
| 2026-06-09 |
CVRx Announces Chief Financial Officer Transition
MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Jared Oasheim, |
| 2026-05-27 |
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
MINNEAPOLIS, May 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management |
| 2026-05-20 |
CVRx to Present at the William Blair 46th Annual Growth Stock Conference
MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management |
| 2026-05-14 |
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy
MINNEAPOLIS, May 14, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Humana has issued |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-11 | Canaccord Genuity's 46th Annual Growth Conference | Conference |
| 2026-08-06 | CVRx Q2 2026 Earnings Call | Earnings call |
| 2026-06-10 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-02 | William Blair 46th Annual Growth Stock Conference | Conference |
| 2026-05-11 | CVRx Q1 2026 Earnings Call | Earnings call |
| 2026-02-12 | CVRx Q4 2025 Earnings Call | Earnings call |
| 2026-01-14 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-12-03 | Piper Sandler 37th Annual Healthcare Conference | Conference |
| 2025-11-18 | Jefferies 2025 London Healthcare Conference | Conference |
| 2025-11-05 | CVRx Q3 2025 Earnings Call | Earnings call |
| 2025-08-12 | Canaccord Genuity 45th Annual Growth Conference | Conference |
| 2025-08-04 | CVRx Q2 2025 Earnings Call | Earnings call |
Source: https://ir.cvrx.com/